Journal article

Neuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis. A longitudinal MRI/MRS study

GE Berger, SJ Wood, M Ross, CA Hamer, RM Wellard, G Pell, L Phillips, B Nelson, GP Amminger, AR Yung, G Jackson, D Velakoulis, C Pantelis, H Manji, PD McGorry

Current Pharmaceutical Design | Published : 2012

Abstract

Objectives: To investigate if low-dose lithium may counteract the microstructural and metabolic brain changes proposed to occur in individuals at ultra-high risk (UHR) for psychosis. Methods: Hippocampal T2 relaxation time (HT2RT) and proton magnetic resonance spectroscopy ( 1H-MRS) measurements were performed prior to initiation and following three months of treatment in 11 UHR patients receiving low-dose lithium and 10 UHR patients receiving treatment as usual (TAU). HT2RT and 1H-MRS percentage change scores between scans were compared using repeated measures ANOVA and correlated with behavioural change scores. Results: Low-dose lithium significantly reduced HT2RT compared to TAU (p=0.018)..

View full abstract